最新更新 :
14/12/2024
Infostab
薬剤一覧
まとめ一覧
互換性の検索
Yサイト対応表
引用文献
研究チーム
valistab
ポスター
接続
スポンサー
作成者
ユーザーガイド
ニュースレター
Ofloxacin
化学構造
商品名
商品名、賦形剤は国、製薬会社ごとに異なることがあります
Anzatax
マレーシア
Floxil
メキシコ
Floxitril
インド
Floxstat
エクアドル, コロンビア, メキシコ
Istaflox
メキシコ
Menefloks
トルコ
Oflocare
ペルー
Oflocet
チュニジア, ポルトガル, モロッコ
Oflogyl
ベネズエラ
Ofloxacin
アメリカ
Ofloxacine
フランス
Ofloxin
エジプト
Ofloxol
マレーシア
Surnox
スペイン
Tabrin
ギリシア
Tarivid
アイルランド, イギリス, オランダ, オーストリア, サウジアラビア, スイス, トルコ, ドイツ, ノルウェー, ハンガリー, ポルトガル, ポーランド, ルクセンブルグ
Zanocin
インド, ポーランド
Zanovid
インド
Zenflox
インド
引用文献 : Ofloxacin
形式
出版物
59
雑誌
Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
182
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
249
雑誌
Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
299
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301
雑誌
Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
444
雑誌
Bornstein M, Kao SH, Mercorelli M, Verma S.
Stability of an ofloxacin injection in various infusion fluids.
Am J Hosp Pharm 1992 ; 49: 2756-2760.
889
雑誌
Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
921
雑誌
Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1410
雑誌
Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1415
雑誌
Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1423
雑誌
Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1481
雑誌
Messerschmidt W.
Kompatibilität von ofloxacin mit ampicillin.
Krankenhauspharmazie 1994 ; 9: 337-340.
1625
雑誌
Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1668
雑誌
Zhang Y, Xu QA, Trissel LA, Williams KY.
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Ann Pharmacotherapy 2000 ; 34: 996-1001.
1712
雑誌
Trissel LA, Saenz CA.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 230-233.
1713
雑誌
Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721
雑誌
Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1754
雑誌
Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1925
雑誌
Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
2139
雑誌
Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
EJHP Science 2006 ; 12,5: 96-99.
2155
雑誌
Battista C, Kane MP, Moon DG, Bailie GR.
Stability of ofloxacin in peritoneal dialysis solutions.
Perit Dial Int 1995 ; 15: 72-74.
3562
実験
Ofloxacin (Tarivid®) - Summary of Product Characteristics
Sanofi 2014
3791
ポスター
Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3883
実験
Ceftazidime - Résumé des caractéristiques du produit
Arrow 2016
Mentions Légales